Studies by Fazioli et al. and Castagnino et al. have shown that Eps8 directly binds to the JXM domain of EGFR and is phosphorylated, which activates a series of downstream signaling pathways [20, 27], and thus promotes tumor progression. Here, EPS8 is linked to neoplasm.